Profil
Laura Barrow worked as Vice President-Clinical Operations at Achillion Pharmaceuticals, Inc. from 2018 to 2020.
Prior to that, she held the same position at Synergy Pharmaceuticals LLC in 2011 and 2012.
Dr. Barrow earned a doctorate degree from St. John's University.
Ehemalige bekannte Positionen von Laura Barrow
| Unternehmen | Position | Ende |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28.01.2020 |
| SYNERGY PHARMACEUTICALS INC | Geschäftsführer | - |
Ausbildung von Laura Barrow
| St. John's University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
